Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.

Dhawan, Ravinder

Diels, Joris K.

van de Velde, Helgi

Spencer, Michael D.

Delforge, Michel

Dimopoulos, Meletios A.

De Samblanx, Hadewijch M.

Roussou, Maria G.

Zervas, Konstantinos

Katodritou, Eirini

Sargin, Deniz

Hulin, Cyrille

Ahlberg, Lucia

De La Rubia, Javier

Ganguly, Rita